Jane Street
CRBP icon

Jane Street’s Corbus Pharmaceuticals CRBP Stock Holding History

Jane Street’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Sell
19,400
-9,200
-32% -$87.1K ﹤0.01% 10198
2026
Q1 		$269K Buy
+28,600
New +$241K ﹤0.01% 9477
2025
Q1 		– Sell
-448,600
Closed -$5.29M – 9574
2024
Q4 		$5.29M Buy
448,600
+317,600
+242% +$5.33M ﹤0.01% 2587
2024
Q3 		$2.7M Buy
+131,000
New +$6.7M ﹤0.01% 3904
2022
Q1 		– Sell
-1,037
Closed -$19K – 10369
2021
Q4 		$19K Sell
1,037
-123
-11% -$3.33K ﹤0.01% 9804
2021
Q3 		$35K Sell
1,160
-2,540
-69% -$100K ﹤0.01% 9641
2021
Q2 		$203K Sell
3,700
-920
-20% -$51.1K ﹤0.01% 8798
2021
Q1 		$273K Sell
4,620
-2,567
-36% -$169K ﹤0.01% 7826
2020
Q4 		$270K Sell
7,187
-20,526
-74% -$767K ﹤0.01% 6557
2020
Q3 		$1.5M Buy
27,713
+22,373
+419% +$4.05M ﹤0.01% 3459
2020
Q2 		$1.34M Buy
+5,340
New +$1.08M ﹤0.01% 3642

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Jane Street's CRBP Position: Q2 2026 in Review

Jane Street increased its Corbus Pharmaceuticals (CRBP) stake by 90% in Q2 2026, buying an estimated $624K and bringing the position to 139,133 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #5977.

Jane Street first reported a position in CRBP in Q3 2016 and has held it in 22 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Jane Street held 139,133 shares of Corbus Pharmaceuticals worth $1.31M as of Q2 2026.
  • Jane Street bought 65,940 Corbus Pharmaceuticals shares in Q2 2026, an estimated $624K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5977 holding.
  • Jane Street first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 22 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.